Literature DB >> 7505283

Poly A-linked colorimetric microtiter plate assay for HIV reverse transcriptase.

K Suzuki1, B P Craddock, N Okamoto, T Kano, R T Steigbigel.   

Abstract

An assay for detection of the reverse transcriptase (RT) of the human immunodeficiency virus (HIV) was developed using poly A linked to microtiter plate with colorimetric detection of incorporated biotin deoxyuridine triphosphate (biotin-dUTP). During the RT reaction, biotin-dUTP was incorporated into oligodeoxythymidylic acid (oligo-dT) which had been hybridized with poly A. At the detection step, horseradish peroxidase conjugated streptavidin was added, followed by the reaction of a colorimetric substrate for this enzyme. This method was contrasted with the two standard isotopic RT assays. There was excellent correlation between the colorimetric RT assay and each of two isotopic RT assays for both detection and quantification of avian myoblastosis virus reverse transcriptase (AMV-RT) and of HIV RT in human lymphocytes infected in vitro with HIV-1. The total assay required for performing the colorimetric assay, including the RT reaction, was 40 min.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7505283     DOI: 10.1016/0166-0934(93)90054-u

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  17 in total

1.  Transcriptional gene silencing of HIV-1 through promoter targeted RNA is highly specific.

Authors:  Kazuo Suzuki; Takaomi Ishida; Makoto Yamagishi; Chantelle Ahlenstiel; Sanjay Swaminathan; Katharine Marks; Daniel Murray; Erin M McCartney; Michael R Beard; Marina Alexander; Damian F J Purcell; David A Cooper; Toshiki Watanabe; Anthony D Kelleher
Journal:  RNA Biol       Date:  2011-11-01       Impact factor: 4.652

2.  A role for urokinase-type plasminogen activator in human immunodeficiency virus type 1 infection of macrophages.

Authors:  M A Handley; R T Steigbigel; S A Morrison
Journal:  J Virol       Date:  1996-07       Impact factor: 5.103

3.  Synthesis of novel derivatives of 4-amino-3-(2-furyl)-5-mercapto-1,2,4-triazole as potential HIV-1 NNRTIs.

Authors:  Jingde Wu; Xinyong Liu; Xianchao Cheng; Yuan Cao; Defeng Wang; Zhong Li; Wenfang Xu; Christophe Pannecouque; Myriam Witvrouw; Erik De Clercq
Journal:  Molecules       Date:  2007-08-22       Impact factor: 4.411

4.  FRET-based assay to screen inhibitors of HIV-1 reverse transcriptase and nucleocapsid protein.

Authors:  Kamal K Sharma; Frédéric Przybilla; Tobias Restle; Julien Godet; Yves Mély
Journal:  Nucleic Acids Res       Date:  2016-01-13       Impact factor: 16.971

5.  Targeting the entrance channel of NNIBP: Discovery of diarylnicotinamide 1,4-disubstituted 1,2,3-triazoles as novel HIV-1 NNRTIs with high potency against wild-type and E138K mutant virus.

Authors:  Ye Tian; Zhaoqiang Liu; Jinghan Liu; Boshi Huang; Dongwei Kang; Heng Zhang; Erik De Clercq; Dirk Daelemans; Christophe Pannecouque; Kuo-Hsiung Lee; Chin-Ho Chen; Peng Zhan; Xinyong Liu
Journal:  Eur J Med Chem       Date:  2018-03-23       Impact factor: 6.514

6.  Direct evidence of nuclear Argonaute distribution during transcriptional silencing links the actin cytoskeleton to nuclear RNAi machinery in human cells.

Authors:  Chantelle L Ahlenstiel; Heidi G W Lim; David A Cooper; Takaomi Ishida; Anthony D Kelleher; Kazuo Suzuki
Journal:  Nucleic Acids Res       Date:  2011-11-07       Impact factor: 16.971

7.  Protein methylation is required to maintain optimal HIV-1 infectivity.

Authors:  Nicole M Willemsen; Eleanor M Hitchen; Tracey J Bodetti; Ann Apolloni; David Warrilow; Sabine C Piller; David Harrich
Journal:  Retrovirology       Date:  2006-12-15       Impact factor: 4.602

8.  Prolonged transcriptional silencing and CpG methylation induced by siRNAs targeted to the HIV-1 promoter region.

Authors:  Kazuo Suzuki; Toshiaki Shijuuku; Toshihiko Fukamachi; John Zaunders; Gilles Guillemin; David Cooper; Anthony Kelleher
Journal:  J RNAi Gene Silencing       Date:  2005-10-11

9.  Closed chromatin architecture is induced by an RNA duplex targeting the HIV-1 promoter region.

Authors:  Kazuo Suzuki; Torsten Juelich; Heidi Lim; Takaomi Ishida; Toshiki Watanebe; David A Cooper; Sudha Rao; Anthony D Kelleher
Journal:  J Biol Chem       Date:  2008-06-02       Impact factor: 5.157

10.  Promoter Targeting shRNA Suppresses HIV-1 Infection In vivo Through Transcriptional Gene Silencing.

Authors:  Kazuo Suzuki; Shinichiro Hattori; Katherine Marks; Chantelle Ahlenstiel; Yosuke Maeda; Takaomi Ishida; Michelle Millington; Maureen Boyd; Geoff Symonds; David A Cooper; Seiji Okada; Anthony D Kelleher
Journal:  Mol Ther Nucleic Acids       Date:  2013-12-03       Impact factor: 10.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.